Suicide in schizophrenia, clozapine, and adoption of evidence-based medicine.
Meltzer
Herbert Y
HY
Vanderbilt University School of Medicine, Nashville, TN 37212, USA. herbert.meltzer@Vanderbilt.edu
D000380:Agranulocytosis / Q000139:chemically induced; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003024:Clozapine / Q000009:adverse effects / Q000627:therapeutic use*; D016903:Drug Monitoring; D004363:Drug Utilization / Q000706:statistics & numerical data; D019317:Evidence-Based Medicine; D006801:Humans; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data; D012307:Risk Factors; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D013405:Suicide / Q000523:psychology / Q000706:statistics & numerical data; D014481:United States; D000092864:Suicide Prevention
D014150:Antipsychotic Agents; D003024:Clozapine